Literature DB >> 23083557

Theranostic imaging of cancer.

Marie-France Penet1, Zhihang Chen, Samata Kakkad, Martin G Pomper, Zaver M Bhujwalla.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23083557      PMCID： PMC4066813          DOI： 10.1016/S0720-048X(12)70051-7

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN： 0720-048X            Impact factor:   3.528


× No keyword cloud information.
  13 in total

Review 1.  A unique folate hydrolase, prostate-specific membrane antigen (PSMA): a target for immunotherapy?

Authors:  J Tasch; M Gong; M Sadelain; W D Heston
Journal:  Crit Rev Immunol       Date:  2001       Impact factor: 2.214

2.  [(11)C]Choline positron emission tomography/computed tomography for staging and restaging of patients with advanced prostate cancer.

Authors:  Murat Tuncel; Michael Souvatzoglou; Ken Herrmann; Jens Stollfuss; Tibor Schuster; Gregor Weirich; Hans-Jürgen Wester; Markus Schwaiger; Bernd J Krause
Journal:  Nucl Med Biol       Date:  2008-08       Impact factor: 2.408

Review 3.  HER-2-positive metastatic breast cancer: trastuzumab and beyond.

Authors:  Giulio Metro; Marcella Mottolese; Alessandra Fabi
Journal:  Expert Opin Pharmacother       Date:  2008-10       Impact factor: 3.889

Review 4.  Maintenance treatment in metastatic breast cancer.

Authors:  A Sánchez-Muñoz; E Pérez-Ruiz; N Ribelles; A Márquez; Emilio Alba
Journal:  Expert Rev Anticancer Ther       Date:  2008-12       Impact factor: 4.512

Review 5.  Emerging drugs in metastatic breast cancer.

Authors:  Omer Dizdar; Kadri Altundag
Journal:  Expert Opin Emerg Drugs       Date:  2009-03       Impact factor: 4.191

Review 6.  The role of HER2 in early breast cancer metastasis and the origins of resistance to HER2-targeted therapies.

Authors:  Jaclyn A Freudenberg; Qiang Wang; Makoto Katsumata; Jeffrey Drebin; Izumi Nagatomo; Mark I Greene
Journal:  Exp Mol Pathol       Date:  2009-05-18       Impact factor: 3.362

7.  Anti-tumor effects and lack of side effects in mice of an immunotoxin directed against human and mouse prostate-specific membrane antigen.

Authors:  Xianming Huang; Mary Bennett; Philip E Thorpe
Journal:  Prostate       Date:  2004-09-15       Impact factor: 4.104

8.  Bioisosterism of urea-based GCPII inhibitors: Synthesis and structure-activity relationship studies.

Authors:  Haofan Wang; Youngjoo Byun; Cyril Barinka; Mrudula Pullambhatla; Hyo-Eun C Bhang; James J Fox; Jacek Lubkowski; Ronnie C Mease; Martin G Pomper
Journal:  Bioorg Med Chem Lett       Date:  2009-10-24       Impact factor: 2.823

9.  Image-guided enzyme/prodrug cancer therapy.

Authors:  Cong Li; Marie-France Penet; Paul Winnard; Dmitri Artemov; Zaver M Bhujwalla
Journal:  Clin Cancer Res       Date:  2008-01-15       Impact factor: 12.531

10.  The homodimer of prostate-specific membrane antigen is a functional target for cancer therapy.

Authors:  Norbert Schülke; Olga A Varlamova; Gerald P Donovan; Dangshe Ma; Jason P Gardner; Donna M Morrissey; Robert R Arrigale; Cenchen Zhan; Amy J Chodera; Kenneth G Surowitz; Paul J Maddon; Warren D W Heston; William C Olson
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-28       Impact factor: 11.205
View more
  7 in total

1.  Novel Structured Reporting Systems for Theranostic Radiotracers.

Authors:  Rudolf A Werner; Ralph A Bundschuh; Lena Bundschuh; Stefano Fanti; Mehrbod S Javadi; Takahiro Higuchi; Alexander Weich; Kenneth J Pienta; Andreas K Buck; Martin G Pomper; Michael A Gorin; Ken Herrmann; Constantin Lapa; Steven P Rowe
Journal:  J Nucl Med       Date:  2019-02-22       Impact factor: 10.057

Review 2.  Assessing the barriers to image-guided drug delivery.

Authors:  Gregory M Lanza; Chrit Moonen; James R Baker; Esther Chang; Zheng Cheng; Piotr Grodzinski; Katherine Ferrara; Kullervo Hynynen; Gary Kelloff; Yong-Eun Koo Lee; Anil K Patri; David Sept; Jan E Schnitzer; Bradford J Wood; Miqin Zhang; Gang Zheng; Keyvan Farahani
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2013-10-31

Review 3.  Trends towards Biomimicry in Theranostics.

Authors:  Michael Evangelopoulos; Alessandro Parodi; Jonathan O Martinez; Ennio Tasciotti
Journal:  Nanomaterials (Basel)       Date:  2018-08-21       Impact factor: 5.076

Review 4.  Nanotechnology in Kidney and Islet Transplantation: An Ongoing, Promising Field.

Authors:  Wei Wang; Ya Teng; Ji-Ji Xue; Hong-Kai Cai; Yu-Biao Pan; Xing-Nan Ye; Xin-Li Mao; Shao-Wei Li
Journal:  Front Immunol       Date:  2022-04-08       Impact factor: 8.786

5.  Tetracyclic Thioxanthene Derivatives: Studies on Fluorescence and Antitumor Activity.

Authors:  Fernando Durães; Patrícia M A Silva; Pedro Novais; Isabel Amorim; Luís Gales; Cátia I C Esteves; Samuel Guieu; Hassan Bousbaa; Madalena Pinto; Emília Sousa
Journal:  Molecules       Date:  2021-05-31       Impact factor: 4.411

Review 6.  Theranostic Pretargeting Drug Delivery and Imaging Platforms in Cancer Precision Medicine.

Authors:  Sudath Hapuarachchige; Dmitri Artemov
Journal:  Front Oncol       Date:  2020-07-22       Impact factor: 6.244

Review 7.  Prospects for Theranostics in Neurosurgical Imaging: Empowering Confocal Laser Endomicroscopy Diagnostics via Deep Learning.

Authors:  Mohammadhassan Izadyyazdanabadi; Evgenii Belykh; Michael A Mooney; Jennifer M Eschbacher; Peter Nakaji; Yezhou Yang; Mark C Preul
Journal:  Front Oncol       Date:  2018-07-03       Impact factor: 6.244
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.